Literature DB >> 17962877

Toxoplasma gondii infection in pregnancy.

Fabiana Maria Ruiz Lopes1, Daniela Dib Gonçalves, Regina Mitsuka-Breganó, Roberta Lemos Freire, Italmar Teodorico Navarro.   

Abstract

Toxoplasmosis is caused by an intracellular protozoan, Toxoplasma gondii, which has a wide geographical distribution. The main infection routes are ingestion of cysts from raw or badly-cooked meat, ingestion of oocysts from substrates contaminated with the feces of infected felines and congenital transmission by tachyzoites. The congenital form results in a severe systemic disease, because if the mother is infected for the first time during gestation, she can present a temporary parasitemia that will infect the fetus. Many of the clinical symptoms are seen in congenitally-infected children, from a mild disease to serious signs, such as mental retardation. Early diagnosis during the pregnancy is highly desirable, allowing prompt intervention in cases of infection, through treatment of pregnant women, reducing the probability of fetal infection and consequent substantial damage to the fetus. Conventional tests for establishment of a fetal diagnosis of toxoplasmosis include options from serology to PCR. Prevention of human toxoplasmosis is based on care to avoid infection, understanding the disease and serological exams during gestation. Pregnant women should be tested serologically from three months gestation, until one month after childbirth. Inclusion of serology for congenital toxoplasmosis along with the basic Guthrie test for PKU is of fundamental importance for early diagnosis of infection and so that treatment is initiated, in order to avoid possible sequels in the infant.

Entities:  

Mesh:

Year:  2007        PMID: 17962877     DOI: 10.1590/s1413-86702007000500011

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  17 in total

1.  Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan.

Authors:  Makiko Sakikawa; Shunichi Noda; Masachi Hanaoka; Hirotoshi Nakayama; Satoshi Hojo; Shigeko Kakinoki; Maki Nakata; Takashi Yasuda; Tsuyomu Ikenoue; Toshiyuki Kojima
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

2.  Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice.

Authors:  Kyoung-Ho Pyo; Bong-Kwang Jung; Jong-Yil Chai; Eun-Hee Shin
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

Review 3.  Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.

Authors:  Gabriella de Lima Bessa; Ricardo Wagner de Almeida Vitor; Erica Dos Santos Martins-Duarte
Journal:  Parasitol Res       Date:  2021-08-14       Impact factor: 2.289

4.  Toxoplasma gondii in raccoons (Procyon lotor) in Germany: a serosurvey based on meat juice.

Authors:  Lydia Engel; Ahmad Hamedy; Aleksandra Kornacka-Stackonis; Torsten Langner; Stefan Birka; Martin Koethe
Journal:  Parasitol Res       Date:  2022-09-23       Impact factor: 2.383

Review 5.  The Experimental Role of Medicinal Plants in Treatment of Toxoplasma gondii Infection: A Systematic Review.

Authors:  Kourosh Cheraghipour; Leila Masoori; Behrooz Ezzatpour; Mona Roozbehani; Ali Sheikhian; Vahid Malekara; Massumeh Niazi; Omid Mardanshah; Kobra Moradpour; Hossein Mahmoudvand
Journal:  Acta Parasitol       Date:  2020-11-06       Impact factor: 1.440

6.  Genomic data reveal Toxoplasma gondii differentiation mutants are also impaired with respect to switching into a novel extracellular tachyzoite state.

Authors:  Pamela J Lescault; Ann B Thompson; Veerupaxagouda Patil; Dario Lirussi; Amanda Burton; Juan Margarit; Jeffrey Bond; Mariana Matrajt
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

7.  Prevalence of immunity to toxoplasmosis among Iranian childbearing age women: Systematic review and meta-analysis.

Authors:  Sedigheh Borna; Mamak Shariat; Mohaddese Fallahi; Leila Janani
Journal:  Iran J Reprod Med       Date:  2013-11

8.  Evaluation of Immune Responses Induced by GRA7 and ROP2 Genes by DNA Vaccine Cocktails Against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Hossein Vazini; Fatemeh Ghafarifar; Zohreh Sharifi; Abdolhosein Dalimi
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jan-Mar

9.  Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso.

Authors:  Sanata Bamba; Mamoudou Cissé; Ibrahim Sangaré; Adama Zida; Souleymane Ouattara; Robert T Guiguemdé
Journal:  BMC Infect Dis       Date:  2017-07-11       Impact factor: 3.090

10.  Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand.

Authors:  Hemah Andiappan; Veeranoot Nissapatorn; Nongyao Sawangjaroen; Waenurama Chemoh; Yee Ling Lau; Thulasi Kumar; Subashini Onichandran; Chitkasaem Suwanrath; Verapol Chandeying
Journal:  Parasit Vectors       Date:  2014-05-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.